Compare Hims and Hers Health Inc (HIMS) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23, down 0.42% on the day, while maintaining a bullish technical trend per moving averages. The fund's low 0.08% expense ratio and 3.4% trailing yield appeal to cost-conscious income investors. Recent news highlights a quiet revival in REIT ETFs, with XLRE gaining 11% year-to-date as of late May 2026, defying broader rate pressures amid shifting Fed expectations.

The outlook for XLRE is cautiously optimistic, supported by solid REIT fundamentals and potential as a geopolitical hedge. Key opportunities include attractive valuations and dividend sustainability, but risks persist from interest rate volatility and inflation concerns that could pressure real estate valuations and investor sentiment in the near term.